
Harvard scientist to test oral rejuvenation drug in XPrize longevity competition
The $101 million Healthspan Competition, funded by Saudi Arabia’s Hevolution Foundation, challenges teams to demonstrate a 10-year improvement in apparent age. Sinclair’s approach uses chemical reprogramming to mimic embryonic gene effects systemically.